Large gap with delayed quotes
|
Last quote
09/11/2026
-
17:30:17
|
Bid
09/11/2026 -
17:40:00
|
Bid Volume |
Ask
09/11/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
27.20
+0.70
(
+2.64% )
|
27.00
|
3,686 |
28.50
|
25 |
Analysis date: 08.09.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 08.09.2026.
Interest
Weak
Weak
Two stars since 04.09.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 04.09.2026 at a price of 28.00.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 04.09.2026.
4wk Rel Perf
5.25%
5.25%
The four-week dividend-adjusted overperformance versus STOXX600 is 5.25%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 08.09.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.38%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.76%.
Mkt Cap in $bn
0.20
0.20
With a market capitalization <$2bn, BIOVERSYS AG is considered a small-cap stock.
G/PE Ratio
-0.61
-0.61
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-7.13
-7.13
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-4.34%
-4.34%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
48
48
For 1% of index variation, the stock varies on average by 0.48%.
Correlation
0.13
0.13
Stock movements are totally independent of index variations.
Value at Risk
6.84
6.84
The value at risk is estimated at CHF 6.84. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.04.2026
21.04.2026